DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Fludeoxyglucose f-18is the generic ingredient in one branded drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Cpdc, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Lantheus Medical, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Petnet, Precision Nuclear, Queen Hamamatsu Pet, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wi Medcl Cyclotron, and Wusm Cyclotron, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.
There are eight drug master file entries for fludeoxyglucose f-18. Twenty-seven suppliers are listed for this compound.
Recent Clinical Trials for fludeoxyglucose f-18
Identify potential brand extensions & 505(b)(2) entrants
|NRG Oncology||Phase 2/Phase 3|
|CHU de Quebec-Universite Laval||Phase 2|
|ECOG-ACRIN Cancer Research Group||Phase 3|
Pharmacology for fludeoxyglucose f-18
|Drug Class||Radioactive Diagnostic Agent |
|Mechanism of Action||Radiopharmaceutical Activity |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Univ Tx Sw Medctr||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||210265-001||Feb 6, 2020||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Ucsf Rodiopharm||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||203902-001||May 9, 2014||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Biomedcl Res Fdn||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||203710-001||May 1, 2015||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Hot Shots Nm Llc||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||203937-001||Oct 30, 2014||RX||No||No||Start Trial||Start Trial||Start Trial|
|Wusm Cyclotron||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||203935-001||Feb 5, 2014||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Trustees Univ Pa||FLUDEOXYGLUCOSE F18||fludeoxyglucose f-18||INJECTABLE;INTRAVENOUS||203801-001||Oct 29, 2014||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.